Table 2.
Compounds | Promoted Survival Rate (%) | ||
---|---|---|---|
45 μmol/L | 90 μmol/L | 180 μmol/L | |
Blank control | 17.81 ± 1.34 | ||
Negative control | 16.56 ±1.66 | 17.69 ± 1.68 | 15.12 ± 1.87 |
Baicalin | 21.53 ±1.17 ** | 26.24 ±2.08 ** | 39.30 ± 2.31 ** |
1 | 20.88 ±1.41 * | 25.92 ±2.23 ** | 31.53 ± 2.39 ** |
2 | 18.07 ± 1.83 | 23.56 ±2.64 ** | 30.52 ± 2.49 ** |
3 | 17.27 ±1.61 | 24.15 ± 1.76 ** | 28.02 ± 2.45 ** |
4 | 18.24 ±1.09 | 20.25± 1.47 ** | 27.89 ±1.57 * |
5 | 16.16 ±0.21 | 20.88 ±1.41 * | 25.67 ± 1.83 ** |
6 | 19.35 ± 1.53 | 24.71 ± 2.75 ** | 38.27 ±3.24 ** |
7 | 18.82 ± 1.23 | 21.07 ± 2.35 * | 25.76 ± 1.19 ** |
Date were expressed as mean±SD (n = 3). Statistical significance was determined by Student t-test. * p < 0.05, ** p < 0.01 as compared with the control.